No accord for the ACCORD-Lipid trial results

被引：1
|
作者：
Matfin, Glenn [1 ,2 ]
Thorne, Matthew [3 ]
机构：
[1] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02215 USA
[2] NYU, Sch Med, Div Endocrinol, New York, NY USA
[3] SAGE Publicat Ltd, London, England
来源：
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM | 2010年 / 1卷 / 02期
关键词：
D O I：
10.1177/2042018810376023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：47 / 49
页数：3
相关论文
共 50 条
  • [1] The ACCORD LIPID Trial
    Abate, Nicola
    Chandalia, Manisha
    METABOLIC SYNDROME AND RELATED DISORDERS, 2010, 8 (05) : 373 - 374
  • [2] Role of fibrates in cardiovascular disease prevention, the ACCORD-Lipid perspective
    Elam, Marshall
    Lovato, Laura C.
    Ginsberg, Henry
    CURRENT OPINION IN LIPIDOLOGY, 2011, 22 (01) : 55 - 61
  • [3] Hypertriglyceridemia and Low HDL-C Predicts Fenofibrate Response in The ACCORD-Lipid Trial
    Elam, Marshall B.
    Lovato, Laura C.
    Byington, Robert P.
    Bonds, Denise
    Leiter, Lawrence
    Crouse, John R.
    Linz, Peter
    Marcovina, Santica
    O'Connor, Patrick J.
    Ginsberg, Henry N.
    CIRCULATION, 2010, 122 (21)
  • [4] Descriptions and Interpretations of the ACCORD-Lipid Trial in the News and Biomedical Literature A Cross-Sectional Analysis
    Downing, Nicholas S.
    Cheng, Theresa
    Krumholz, Harlan M.
    Shah, Nilay D.
    Ross, Joseph S.
    JAMA INTERNAL MEDICINE, 2014, 174 (07) : 1176 - 1182
  • [5] The ACCORD-Lipid study: implications for treatment of dyslipidemia in Type 2 diabetes mellitus
    Elam, Marshall
    Lovato, Laura
    Ginsberg, Henry
    CLINICAL LIPIDOLOGY, 2011, 6 (01) : 9 - 20
  • [6] Effect of Fenofibrate Therapy on Cardiovascular Disease in Men versus Women with Type 2 Diabetes in the ACCORD-Lipid Trial
    Lovato, Laura C.
    Elam, Marshall B., III
    Byington, Robert P.
    Sweeney, Mary E., III
    Sperl-Hillen, Joann M.
    Fleg, Jerome
    Weiss, Daniel
    Lorber, Daniel L.
    Ginsberg, Henry N.
    CIRCULATION, 2010, 122 (21)
  • [7] RESULTS OF ACCORD 12 TRIAL IN RECTAL CANCER
    Gerard, J. P.
    Gourgou-Bourgade, S.
    Azria, O.
    Martel-Lafay, L.
    Hennequin, C.
    Conroy, T.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S104 - S104
  • [8] PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid
    Morieri, Mario Luca
    Shah, Hetal S.
    Sjaarda, Jennifer
    Lenzini, Petra A.
    Campbell, Hannah
    Motsinger-Reif, Alison A.
    Gao, He
    Lovato, Laura
    Prudente, Sabrina
    Pandolfi, Assunta
    Pezzolesi, Marcus G.
    Sigal, Ronald J.
    Pare, Guillaume
    Marcovina, Santica M.
    Rotroff, Daniel M.
    Patorno, Elisabetta
    Mercuri, Luana
    Trischitta, Vincenzo
    Chew, Emily Y.
    Kraft, Peter
    Buse, John B.
    Wagner, Michael J.
    Cresci, Sharon
    Gerstein, Hertzel C.
    Ginsberg, Henry N.
    Mychaleckyj, Josyf C.
    Doria, Alessandro
    DIABETES, 2020, 69 (04) : 771 - 783
  • [9] ACCORD Blood Pressure and ACCORD Lipid: how low can we go?
    Mariela Glandt
    Itamar Raz
    Nature Reviews Endocrinology, 2010, 6 : 483 - 484
  • [10] Clinical Implications of the ACCORD Trial
    Genuth, S.
    Ismail-Beigi, F.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (01): : 41 - 48
12345